Abstract
The present work deals with the anticancer effect of benzimidazole derivatives associated with the pyridine framework. By varying the functional group at N-terminal of the benzimidazole by different L-amino acids, several 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1Hbenzo[d]imidazole derivatives 9(a–j) were synthesized. Their chemical structures were confirmed by 1H NMR, IR and mass spectroscopic techniques. The synthesized compounds were examined for their antiproliferative effects against human leukemia cell lines, K562 and CEM. The preliminary results showed most of the derivatives had moderate antitumor activity. Compound 9j containing cysteine residue exhibited good inhibition compared to other amino acid resides. In addition DNA fragmentation results suggest that 9j is more cytotoxic and able to induce apoptosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aibin, W., Yufang X., and Xuhong Q., Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain Design, synthesis and potential antitumor activity. Bioorg. Med. Chem., 17, 592–599 (2009).
Andrzejewska, M., Yepez-Mulia, L., Cedillo-Rivera, R., Tapia, A., Vilpo, L., Vilpo, J., and Kazimierczuk, Z., Synthesis, antiprotozoal and anticancer activity of substituted 2-trifluoromethyl and 2-pentafluoroethylbenzimidazoles. Eur. J. Med. Chem., 37, 973–978 (2002).
Ananda Kumar, C. S., Kavitha, C. V., Vinaya, K., Benaka Prasad, S. B., Thimmegowda, N. R., Chandrappa, S., Raghavan, S. C., and Rangappa, K. S., Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: A SAR study. Invest. New Drugs, doi:10.1007/s10637-008-9179-3. (2008).
Chandrappa, S., Kavitha, C. V., Shahabuddin, M. S., Vinaya, K., Ananda Kumar, C. S., Ranganatha., S. R., Raghavan S. C., and Rangappa, K. S., Synthesis of 2-(5-((5-(4-chlorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid derivatives and evaluation of their cytotoxicity and induction of apoptosis in human leukemia cells. Bioorg. Med. Chem., 17, 2576–2584 (2009).
Chapman., and Hall., Chemistry of Antitumor Agents, Wilman. D. E. V. Ed., New York, (1990).
Goker, H., Kus, C., Boykin, D. W., Yildiz, S., and Altanlar, N., Synthesis of some new 2-substituted-phenyl-1H-benzimidazole-5-carbonitriles and their potent activity against candida species. Bioorg. Med. Chem., 10, 2589–2596 (2002).
Goker, H., Ozden, S., Yýldýz, S., and Boykin, D. W., Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines. Eur. J. Med. Chem., 40, 1062–1069 (2005).
Kavitha, C. V., Nambiar, M., Ananda Kumar, C. S., Choudhary, B., Muniyappa, K., Rangappa, K. S., and Raghavan, S. C., Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochem. Pharmacol., 77, 348–363 (2009).
Lemaire, G., Delescluse, C., Pralavorio, M., Ledirac, N., Lesca, P., and Rahmani, R., The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes. Life Sci., 74, 2265–2278 (2004).
Margiotta, N., Papadia, P., Lazzaro, F., Crucianelli, M., Angelis, F. D., Pisano, C., Vesci, L., and Natile, G., Platinum-based antitumor drugs containing enantiomerically pure alpha-trifluoromethyl alanine as ligand. J. Med. Chem., 48, 7821–7828 (2005).
Mavrova, A. T., Anichina, K. K., Vuchev, D. I., Tsenov, J. A., Kondeva, M. S., and Micheva, M. K., Synthesis and antitrichinellosis activity of some 2-substituted-[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-ones. Bioorg. Med. Chem., 13, 5550–5559. (2005).
Ozden, S., Atabey, D., Yildiz, S., and Goker, H., Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1H-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups. Bioorg. Med. Chem., 13, 1587–1597 (2005).
Pratt, W. B., Ruddon, R. W., and Ensminger, W. D., The Anticancer Drugs., Oxford University Press, New York, (1994).
Ramla, M. M., Omar, M. A., Abdel-Momen M., El-Khamry, H. I., and El-Diwani., Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles. Bioorg. Med. Chem., 14, 7324–7332 (2006).
Rajski, S. C. and Williams, R. M., DNA cross-linking agents as antitumor drugs. Chem. Rev. 98, 2723–2795 (1998).
Rastogi, R. and Sharma, S., 2-Aminobenzimidazoles in organic syntheses. Synthesis, 861–882 (1983).
Rooseboom, M., Commandeur, J.N., and Vermeulen, N. P., Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol. Rev., 56, 53–102 (2004).
Starcevic, K., Kralj, M., Ester, K., Sabol, I., Grce, M., Pavelic, K., and Karminski-Zamola G., Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles. Bioorg. Med. Chem., 15, 4419–4426 (2007).
Shugar, D., Viral and host-cell protein kinases: Enticing antiviral targets and relevance of nucleoside, and viral thymidine, kinases. Pharmacol. Ther., 82, 315–335 (1999).
Snow, R. J., Abeywardane, A., Campbell, S., Lord, J., Kashem, M. A., Khine, H. H., Josephine, K., Kowalski J. A., Pullen, S. S., Roma, T., Roth, G. P., Sarko, C. R., Wilson, N. S., Winters, M. P., Wolak, J. P., and Cywin, C. L., Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors. Bioorg. Med. Chem. Lett., 17, 3660–3666 (2007).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ranganatha, S.R., Kavitha, C.V., Vinaya, K. et al. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives. Arch. Pharm. Res. 32, 1335–1343 (2009). https://doi.org/10.1007/s12272-009-2000-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-2000-9